Lifecore Biomedical Inc (NAS:LFCR)
$ 5.12 0 (0%) Market Cap: 158.20 Mil Enterprise Value: 279.79 Mil PE Ratio: 22.26 PB Ratio: 13.84 GF Score: 60/100

Q2 2023 Lifecore Biomedical Inc Earnings Call Transcript

Mar 17, 2023 / 12:30PM GMT
Release Date Price: $1.67 (-67.32%)
Operator

Good morning, and thank you for joining the Lifecore Biomedical Fiscal 2023 Second Quarter Earnings Call. (Operator Instructions). Now I'd like to turn the call over to Jeff Sonnek, Investor Relations at ICR. Please go ahead.

Jeff Sonnek
ICR, LLC - SVP

Good morning, and thank you for joining us today to discuss Lifecore Biomedical's Second Quarter Fiscal 2023 Earnings Results and the strategic and commercial update that we provided via a series of concurrent press releases yesterday after the market closed. Hosting the call today from the company are Jim Hall, President and Chief Executive Officer; and John Morberg, Chief Financial Officer.

Before we begin today, I'd like to remind everyone of the safe harbor statement. Certain statements made in the course of this conference call contain forward-looking statements. It is important to note that the company's actual results could differ materially from those projected in such forward-looking statements. Additional information concerning risk factors that could cause actual results to differ materially

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot